Annual Drug Patent Expirations for HEPZATO
Hepzato is a drug marketed by Delcath Systems Inc and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.
This drug has nineteen patent family members in nine countries.
The generic ingredient in HEPZATO is melphalan hydrochloride. One supplier is listed for this compound. Additional details are available on the melphalan hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
